These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2879529)

  • 21. Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.
    Correll CU
    J Am Acad Child Adolesc Psychiatry; 2008 Jan; 47(1):9-20. PubMed ID: 18174821
    [No Abstract]   [Full Text] [Related]  

  • 22. Psychoactive drugs in the elderly: antipsychotics and anxiolytics.
    Jenike MA
    Geriatrics; 1988 Sep; 43(9):53-7, 61-2, 65. PubMed ID: 2900797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dissimilar dosing with high-potency and low-potency neuroleptics.
    Baldessarini RJ; Katz B; Cotton P
    Am J Psychiatry; 1984 Jun; 141(6):748-52. PubMed ID: 6145357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [General practice of acute inpatient treatment of mania. Retrospective comparative study of 100 patients at each of 2 psychiatric centers].
    Adler L; Ulrich M; Lehmann K; Nordeck I; Langer C; Thomas RS; Hajak G; Koller M
    Fortschr Neurol Psychiatr; 1994 Dec; 62(12):479-88. PubMed ID: 7835819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A prospective survey of neuroleptic malignant syndrome in a short-term psychiatric hospital.
    Gelenberg AJ; Bellinghausen B; Wojcik JD; Falk WE; Sachs GS
    Am J Psychiatry; 1988 Apr; 145(4):517-8. PubMed ID: 2894782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
    Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
    Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay.
    Baldessarini RJ; Kando JC; Centorrino F
    Am J Psychiatry; 1995 Jul; 152(7):1038-44. PubMed ID: 7793440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current status of institutionalized mental health patients' right to refuse psychotropic drugs.
    Kemna DJ
    J Leg Med; 1985 Mar; 6(1):107-38. PubMed ID: 2860193
    [No Abstract]   [Full Text] [Related]  

  • 29. Droperidol: efficacy and side effects in psychiatric emergencies.
    Chambers RA; Druss BG
    J Clin Psychiatry; 1999 Oct; 60(10):664-7. PubMed ID: 10549682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Replacement of chlorpromazine with other neuroleptics: effect on abnormal skin pigmentation and ocular changes.
    Lal S; Bloom D; Silver B; Desjardins B; Krishnan B; Thavundayil J; Thompson T
    J Psychiatry Neurosci; 1993 Jul; 18(4):173-7. PubMed ID: 8104031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of the rabbit syndrome.
    Yassa R; Lal S
    Am J Psychiatry; 1986 May; 143(5):656-7. PubMed ID: 2870650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
    Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
    J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmaceutical characteristics of depot neuroleptics. Their use and efficacy in the psychiatric clinic].
    Mungiu OC; Chiriţă V; Boişteanu P; Mungiu A; Cosmovici N; Pirozynski T
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):43-7. PubMed ID: 2899341
    [No Abstract]   [Full Text] [Related]  

  • 34. Advantages and disadvantages of depot-neuroleptics as maintenance medication for chronic schizophrenics.
    Möller HJ; Kissling W
    Clin Neuropharmacol; 1986; 9 Suppl 4():259-62. PubMed ID: 2882841
    [No Abstract]   [Full Text] [Related]  

  • 35. Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.
    Barbui C; Biancosino B; Esposito E; Marmai L; Donà S; Grassi L
    Int Clin Psychopharmacol; 2007 Jul; 22(4):221-5. PubMed ID: 17519645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroleptics in pediatric psychiatry.
    Whitaker A; Rao U
    Psychiatr Clin North Am; 1992 Mar; 15(1):243-76. PubMed ID: 1347940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose treatment with neuroleptics in the acute phase of mental disease.
    Dencker SJ
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):32-4. PubMed ID: 14332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abuse potential of anticholinergics.
    Dose M; Tempel HD
    Pharmacopsychiatry; 2000 Sep; 33 Suppl 1():43-6. PubMed ID: 11072764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of dopamine metabolism for clinical effects and side effects of neuroleptics.
    Van Praag HM; Korf J
    Am J Psychiatry; 1976 Oct; 133(10):1171-7. PubMed ID: 970488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute inpatient treatment of manias. Effects of independent variables on neuroleptic dosage and length of stay].
    Adler L; Ulrich M; Lehmann K; Nordeck I; Langer C; Thomas RS; Hajak G; Koller M
    Nervenarzt; 1996 Mar; 67(3):235-43. PubMed ID: 8901282
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.